Where does ForSight Vision4, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ForSight Vision4, Inc. ranks #7,554 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ForSight Vision4, Inc. hold?

ForSight Vision4, Inc. holds 43 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is ForSight Vision4, Inc.'s Innovation Score?

ForSight Vision4, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ForSight Vision4, Inc.'s patent grant rate increasing or decreasing?

ForSight Vision4, Inc.'s recent grant velocity is +11% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for ForSight Vision4, Inc.'s patents?

ForSight Vision4, Inc.'s patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ForSight Vision4, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ForSight Vision4, Inc.

Q: What technology areas does ForSight Vision4, Inc. focus on?

ForSight Vision4, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 37 patents, ranking #174 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 43 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Forsight ranks #7,554 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 8 technology areas.

#7,554
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 20.2
avg claims per patent: +11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7554 · US Corporation #7,554 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 43 grants
UPPER-Q #7,554/49,997
PHOTO-FINISH Edsal Manufacturing
CPC-NARROW A61F · 8 areas
INNOV-PAR 40.2/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-USCORP US Corporation
VEL-UP +11% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Edsal Manufacturing Company, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Forsight’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (33%) Velocity 5.0 pts (12%) Breadth 10.0 pts (25%) Claim depth 12.1 pts (30%)

Qualcomm Incorporated · highest

85
Banjo · near

40
Biodesix · near

40
ForSight Vision4 · this assignee

40
Kyowa Hakko BIO · near

40
Schölly Fiberoptic · near

40
3D Lighting… · lowest

7

What this shows Forsight's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Forsight?

Each dot is one of Forsight’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Forsight’s own 20.2 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Forsight vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Forsight's grants concentrate

ForSight Vision4, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 86% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2017. By volume, Forsight sits between Edsal Manufacturing Company, LLC and Granbio Intellectual Property Holdings, LLC.

Forsight's three-year grant acceleration

ForSight Vision4, Inc. shows 12 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Edsal Manufacturi…

43
Elektrobit Automo…

43
Evernorth Strateg…

43
Focal Point

43
G1 Therapeutics

43
Getrag Getriebe-…

43
Gowin Semiconduct…

43
Granbio Intellect…

43
Forsight Vision4 ◀

43

What this shows ForSight holds 43 patents at rank #7,554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ForSight

By rank, the assignees closest to #7,554 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ForSight's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ForSight, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), ForSight ranks #174 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Kyowa Hakko BIO Co., Ltd. 40 Schölly Fiberoptic GmbH 40 Biodesix, Inc. 40 Banjo Corporation 40

Forsight's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ForSight Vision4, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.7%
2016	4	9.3%
2017	1	2.3%
2018	5	11.6%
2019	7	16.3%
2020	7	16.3%
2021	2	4.7%
2022	4	9.3%
2023	5	11.6%
2024	3	7.0%
2025partial year	3	7.0%

Which technologies does ForSight Vision4, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 37

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 27

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 21

C07K - Peptides 6

Y10T - Technical Subjects Covered BY Former US Classification 4

A61B - DIAGNOSIS; SURGERY; Identification 2

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ForSight Vision4, Inc.'s patent record in context - here's where to go next.

ForSight Vision4, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 86% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #7,554 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ForSight Vision4, Inc. against Edsal Manufacturing Company, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.